Hacia una nueva clasificación de los métodos anticonceptivos para un mejor desarrollo sostenible. Un enfoque bioético global
Barra lateral del artículo
Contenido principal del artículo
Resumen
Los Objetivos de Desarrollo Sostenible (ODS) 3.7 y 5.6 pretenden lograr el acceso universal a los servicios y derechos de salud sexual y reproductiva para 2030. Estos servicios incluyen la planificación familiar, en particular la anticoncepción. Según las estadísticas de la ONU, el uso de métodos anticonceptivos modernos supera con creces el de los métodos tradicionales. Sin embargo, esta división entre “moderno” y “tradicional” parece tener varias incoherencias. Partiendo de un enfoque bioético global, este artículo pretende proponer una nueva clasificación de los métodos anticonceptivos. La necesidad de una información completa y precisa sobre la planificación familiar, y la participación de ambos miembros de la pareja en las decisiones sobre anticoncepción, son conclusiones clave.
Descargas
PLUMX Metrics
Detalles del artículo
Esta obra está bajo una licencia internacional Creative Commons Atribución-NoComercial-CompartirIgual 4.0.
Medicina y Ética se distribuye bajo Licencia Creative Commons Atribución-NoComercial-CompartirIgual 4.0 Internacional.
El autor conserva los derechos patrimoniales sin restricciones y garantiza a la revista el derecho de ser la primera publicación del trabajo. El autor es libre de depositar la versión publicada en cualquier otro medio, como un repositorio institucional o en su propio sitio web.
Citas
Transforming our world: the 2030 Agenda for Sustainable Development. Resolu- tion adopted by the General Assembly on 25 September 2015 [Internet]. Available from: https://sdgs.un.org/2030agenda
World Health Organization. who. Sexual and reproductive health and rights [Internet]. [cited 2024 Oct 9]. Available from: https://www.who.int/health-topics/sexual-and-reproductive-health-and-rights
United Nations Department of Economic and Social Affairs. World Family Planning 2022. Meeting the changing needs for family planning: Contraceptive use by age and method [Internet]. 4th ed. New York: United Nations; 2022 [cited 2023 Oct 7]. Available from: https://www.un.org/development/desa/pd/sites/www.un.org.development.desa.pd/files/files/documents/2023/Feb/undesa_pd_2022_world-family-planning.pdf
Festin MPR, Kiarie J, Solo J, Spieler J, Malarcher S, Van Look PFA. Moving to- wards the goals of FP2020 — classifying contraceptives. Contraception [Internet]. 2016 Oct [cited 2022 Nov 29]; 94(4):289–94. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5032916/ DOI: https://doi.org/10.1016/j.contraception.2016.05.015
UNDP/UNFPA/UNICEF/WHO/World Bank Special Programme of Research, Development and Research, Training in Human Reproduction (HRP). Annual technical report 2015 [Internet]. Geneva: United Nations; 2016 [cited 2022 Nov 29]. Available from: http://apps.who.int/iris/bitstream/10665/246092/1/WHO-RHR-HRP-16.08-eng.pdf
UNESCO. Universal Declaration on Bioethics and Human Rights (2005) [Internet]. Available from: https://www.unesco.org/en/legal-affairs/universal-declaration-bioethics-and-human-rights
UNESCO. Global bioethics: what for? Twentieth anniversary of UNESCO’s Bioethics Programme [Internet]. Paris: Germán Solinís; 2015 [cited 2024 Oct 9]. Available from: https://unesdoc.unesco.org/ark:/48223/pf0000231159
United Nations, Department of Economic and Social Affairs. Family Planning and the 2030 Agenda for Sustainable Development. Data Booklet [Internet]. New York: United Nations; 2019 [cited 2022 Nov 15]. Available from: https://www.un.org/en/development/desa/population/publications/pdf/family/familyPlanning_DataBook- let_2019.pdf
World Health Organization Department of Sexual and Reproductive Health and Research (WHO/SRH), Johns Hopkins Bloomberg School of Public Health/ Center for Communication Programs (CCP), Knowledge SUCCESS. Family Planning: A Global Handbook for Providers. Evidence-based guidance developed through worldwide collaboration [Internet]. 4th ed. Geneva and Baltimore: World Health Organization and Johns Hopkins; 2022 [cited 2023 Oct 7]. Available from: https://www.who.int/publications/i/item/9780999203705
United Nations, Department of Economic and Social Affairs, Population Division. Contraceptive use by Method 2019. Data Booklet [Internet]. New York: United Nations; 2019 [cited 2022 Nov 26]. Available from: https://www.un.org/development/desa/pd/sites/www.un.org.development.desa.pd/files/files/documents/2020/Jan/un_2019_contraceptiveusebymethod_databooklet.pdf
United Nations. Department of Economic and Social Affairs Statistics [Internet]. 2022 [cited 2022 Nov 25]. SDG Indicators-SDG Indicators. Available from: https://unstats.un.org/sdgs/metadata
United Nations [Internet]. [cited 2022 Oct 30]. un Population Division Data Portal. Interactive access to global demographic indicators. Available from: https://population.un.org/dataportal/home
Bellizzi S, Mannava P, Nagai M, Sobel HL. Reasons for discontinuation of contraception among women with a current unintended pregnancy in 36 low and middle-income countries. Contraception [Internet]. 2020 [cited 2022 Oct 30]; 101(1):26–33. Available from: https://www.sciencedirect.com/science/article/pii/ S0010782419304305 DOI: https://doi.org/10.1016/j.contraception.2019.09.006
SDG Metadata Translation Project [Internet]. [cited 2022 Oct 30]. Indicateur: 3.7.1. Available from: https://worldbank.github.io/sdg-metadata/metadata/fr/3-7-1/
World Health Organization. who. High rates of unintended pregnancies linked to gaps in family planning services: New who study [Internet]. 2019 [cited 2022 Oct 31]. Available from: https://www.who.int/news/item/25-10-2019-high-rates-of-unintended-pregnancies-linked-to-gaps-in-family-planning-services-new-who-study
Contraception Policy Atlas 2023 [Internet]. Brussels: European Parliamentary Fo- rum (EPF) for Sexual & Reproductive Rights; 2023 [cited 2023 May 3] Available from: https://www.epfweb.org/node/89
United Nations. ICPD Programme Action [Internet]. https://www.unfpa.org/icpd-re- design. UNFPA; 2014 [cited 2022 Jan 10]. Available from: https://www.unfpa.org/ icpd-redesign
Gautier-Lavaste C. Planification familiale naturelle. Enquête auprès d’internes en médecine générale : Connaissances, intérêts pour le sujet, enseignement à la faculté et place dans une consultation au cabinet. [Internet] [Thèse de doctorat]. [Par- is]: Université René Descartes- Paris 5; 2007 [cited 2022 Nov 26].
Bodet A. Histoire de la contraception. De la grossesse subie à la grossesse désirée [Internet] [These de doctorat]. [Angers]: Université d’Angers; 2014 [cited 2022 Nov 25]. Available from: https://dune.univ-angers.fr/fichiers/20080073/2014P-PHA3265/fichier/3265F.pdf
Vallet M, Saab-Tsnobiladzé S. Cycle féminin au naturel. Gérer sa fertilité et prendre soin de sa santé gynécologique. Paris: Leduc; 2022.
Creighton Model – Unleashing the power of a woman’s cycle [Internet]. [cited 2024 Oct 9]. Available from: https://creightonmodel.com/
Dakoure CP bamba. L’allaitement maternel exclusif comme méthode de contraception : étude de la méthode de l’allaitement maternel et d’aménorrhée (MAMA) dans deux centres médicaux de la ville de Ouagadougou [Internet] [Thèse de doctorat]. [Angers]: Université de Ouagadougou; 2012 [cited 2022 Nov 26]. Avail- able from: https://beep.ird.fr/collect/uouaga/index/assoc/M13041.dir/M13041.pdf
MMNFP.com[Internet].[cited2024Oct9].The Marquette Method. Available from:
https://www.mmnfp.com/marquettenfp
FEMM Health [Internet]. [cited 2024 Oct 9]. Fertility Education and Medical Management. Available from: https://femmhealth.org/
Sinapov I. BGO Software. 2024 [cited 2024 Oct 9]. What Is Femtech: Solutions and Trends. Available from: https://www.bgosoftware.com/blog/what-is-femtech- solutions-and-trends/
UNWomen.Beijing Declaration and Platform for Action, Beijing + 5 Political Declaration and Outcome [Internet]. 2014th ed. United Nations; 1995 [cited 2022 Jan 10]. Available from: https://www.unwomen.org/en/digital-library/publications/2015/01/beijing-declaration
Finer LB, Henshaw SK. Disparities in Rates of Unintended Pregnancy In the United States, 1994 and 2001. Perspect Sex Reprod Health [Internet]. 2006 [cit- ed 2022 Oct 31]; 38(2):90–6. Available from: https://onlinelibrary.wiley.com/doi/ abs/10.1363/3809006?sid=nlm%3Apubmed DOI: https://doi.org/10.1111/j.1931-2393.2006.tb00065.x
Coombe J, Harris ML, Wigginton B, Loxton D, Lucke J. Contraceptive use at the time of unintended pregnancy: Findings from the Contraceptive Use, Pregnancy Intention and Decisions study. Aust J Gen Pract [Internet]. 2016 Nov [cited 2022 Oct 31]; 45(11):842–8. Available from: https://www.racgp.org.au/afp/2016/november/contraceptive-use-at-the-time-of-unintended-pr-2
Polis C, Bradley SEK, Bankole A, Onda T, Croft TN, Singh S. Contraceptive Failure Rates in the Developing World: An Analysis of Demographic and Health Sur- vey Data in 43 Countries [Internet]. New York: Guttmacher Institute; 2016 Mar [cited 2022 Nov 28] Available from: https://www.guttmacher.org/report/contraceptive-failure-rates-in-developing-world
Hatcher RA, Nelson AL, Trussel J, Cwiak C, Cason P, Policar MS. Contraceptive Technology. 21st ed. Managing Contraception, LLC; 2018.
Frank-Herrmann P, Heil J, Gnoth C, Toledo E, Baur S, Pyper C. The effectiveness of a fertility awareness based method to avoid pregnancy in relation to a couple’s sexual behaviour during the fertile time: a prospective longitudinal study. Hum Reprod [Internet]. 2007 [cited 2022 Nov 24]; 22(5):1310–9. Available from: https://academic.oup.com/humrep/article/22/5/1310/2914315?login=false DOI: https://doi.org/10.1093/humrep/dem003
Qian SZ, Zhang DW, Huai-Zhi Z, Lu RK, Peng L, He CH. Evaluation of Effective- ness of Natural Fertility Regulation Programme in China - WOOMB International [Internet]. Science of Fertility. 2021 [cited 2022 Nov 30]. Available from: https:// woombinternational.org/science-of-fertility/evaluation-of-effectiveness-of-natural-fertility-regulation-programme-in-china/
Peragallo Urrutia R, Polis CB, Jensen ET, Greene ME, Kennedy E, Stanford JB. Effectiveness of Fertility Awareness–Based Methods for Pregnancy Prevention: A Systematic Review. Obstet Gynecol [Internet]. 2018 [cited 2022 Nov 30]; 132(3):591–604. Available from: https://journals.lww.com/greenjournal/Abstract/2018/09000/Effectiveness_of_Fertility_Awareness_Based_Methods.8.aspx DOI: https://doi.org/10.1097/AOG.0000000000002784
Berglund Scherwitzl E, Lundberg O, Kopp Kallner H, Gemzell Danielsson K, Trussell J, Scherwitzl R. Perfect-use and typical-use Pearl Index of a contraceptive mobile app. Contraception [Internet]. 2017 [cited 2024 Oct 9]; 96(6):420–5. Available from: https://www.contraceptionjournal.org/article/S0010-7824(17)30429-8/fulltext DOI: https://doi.org/10.1016/j.contraception.2017.08.014
Bradley SEK, Polis CB, Bankole A, Croft T. Global Contraceptive Failure Rates: Who Is Most at Risk? Stud Fam Plann [Internet]. 2019 [cited 2022 Nov 30]; 50(1):3– 24. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6594038/ DOI: https://doi.org/10.1111/sifp.12085
Hill S. This Is Your Brain on Birth Control: The Surprising Science of Women, Hormones, and the Law of Unintended Consequences. New York: Avery; 2019.
Malmborg A, Persson E, Brynhildsen J, Hammar M. Hormonal contraception and sexual desire: A questionnaire-based study of young Swedish women. Eur J Contracept Reprod Health Care [Internet]. 2016 [cited 2022 Dec 3]; 21(2):158–67. Available from: https://www.tandfonline.com/doi/abs/10.3109/13625187.2015.1079609?- journalCode=iejc20 DOI: https://doi.org/10.3109/13625187.2015.1079609
Battaglia C, Morotti E, Persico N, Battaglia B, Busacchi P, Casadio P. Clitoral vascularization and sexual behavior in young patients treated with drospirenone-ethinyl estradiol or contraceptive vaginal ring: a prospective, randomized, pilot study. J Sex Med [Internet]. 2014 Feb [cited 2023 Apr 20]; 11(2):471–80. Available from: https://www.sciencedirect.com/science/article/abs/pii/S1743609515306792?via%3Dihub DOI: https://doi.org/10.1111/jsm.12392
Skovlund CW, Mørch LS, Kessing LV, Lidegaard Ø. Association of Hormonal Contraception With Depression. JAMA Psychiatry [Internet]. 2016 Nov 1 [cited 2022 Dec 3]; 73(11):1154–62. Available from: https://jamanetwork.com/journals/jama-psychiatry/fullarticle/2552796 DOI: https://doi.org/10.1001/jamapsychiatry.2016.2387
Skovlund CW, Mørch LS, Kessing LV, Lange T, Lidegaard Ø. Association of Hormonal Contraception With Suicide Attempts and Suicides. Am J Psychiatry [In- ternet]. 2018 Apr [cited 2022 Dec 3]; 175(4):336–42. Available from: https://ajp.psychiatryonline.org/doi/10.1176/appi.ajp.2017.17060616 DOI: https://doi.org/10.1176/appi.ajp.2017.17060616
Larsen SV, Mikkelsen AP, Lidegaard Ø, Frokjaer VG. Depression Associated With Hormonal Contraceptive Use as a Risk Indicator for Postpartum Depression. JAMA Psychiatry [Internet]. 2023 Jul 1 [cited 2023 Oct 16]; 80(7):682–9. Available from: https://jamanetwork.com/journals/jamapsychiatry/fullarticle/2804354 DOI: https://doi.org/10.1001/jamapsychiatry.2023.0807
Arnal-Morvan B. Pilule ou pas pilule ? Tout savoir sur les différents moyens de contraception y compris masculins. Vergèze: Thierry Souccar; 2022.
Kuhlmann S, Wolf OT. Cortisol and memory retrieval in women: influence of menstrual cycle and oral contraceptives. Psychopharmacology (Berl) [Internet]. 2005 [cited 2023 May 5]; 183(1):65–71. Available from: https://link.springer.com/article/10.1007/s00213-005-0143-z DOI: https://doi.org/10.1007/s00213-005-0143-z
Bianchini F, Verde P, Colangeli S, Boccia M, Strollo F, Guariglia C. Effects of oral contraceptives and natural menstrual cycling on environmental learning. BMC Womens Health [Internet]. 2018 Nov 7 [cited 2023 May 5]; 18(179). Available from: https://doi.org/10.1186/s12905-018-0671-4 DOI: https://doi.org/10.1186/s12905-018-0671-4
Nielsen SE, Ertman N, Lakhani YS, Cahill L. Hormonal contraception usage is associated with altered memory for an emotional story. Neurobiol Learn Mem [In- ternet]. 2011 Sep 1 [cited 2023 May 5]; 96(2):378–84. Available from: https://www.sciencedirect.com/science/article/pii/S1074742711001249 DOI: https://doi.org/10.1016/j.nlm.2011.06.013
Rumberg B, Baars A, Fiebach J, Ladd ME, Forsting M, Senf W. Cycle and gender-specific cerebral activation during a verb generation task using fMRI: Comparison of women in different cycle phases, under oral contraception, and men. Neurosci Res [Internet]. 2010 Apr 1 [cited 2023 May 5]; 66(4):366–71. Available from: https://www.sciencedirect.com/science/article/pii/S0168010209020951 DOI: https://doi.org/10.1016/j.neures.2009.12.011
Marečková K, Perrin JS, Nawaz Khan I, Lawrence C, Dickie E, McQuiggan DA. Hormonal contraceptives, menstrual cycle and brain response to faces. Soc Cogn Affect Neurosci [Internet]. 2014 Feb 1 [cited 2023 May 5]; 9(2):191–200. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3907931/ DOI: https://doi.org/10.1093/scan/nss128
Chen KX, Worley S, Foster H, Edasery D, Roknsharifi S, Ifrah C. Oral contraceptive use is associated with smaller hypothalamic and pituitary gland volumes in healthy women: A structural MRI study. PLOS One [Internet]. 2021 [cited 2022 Dec 3]; 16(4):e0249482. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8059834/ DOI: https://doi.org/10.1371/journal.pone.0249482
Brouillard A, Davignon LM, Turcotte AM, Marin MF. Morphologic alterations of the fear circuitry: the role of sex hormones and oral contraceptives. Front Endocrinol [Internet]. 2023 [cited 2023 Nov 11]; 14:1–22. Available from: https://www.frontier-sin.org/articles/10.3389/fendo.2023.1228504 DOI: https://doi.org/10.3389/fendo.2023.1228504
Simões TMR, Zapata CLV, Donangelo CM. Influence of hormonal contraceptives on indices of zinc homeostasis and bone remodeling in young adult women. Rev Bras Ginecol E Obstet [Internet]. 2015 [cited 2022 Dec 3]; 37(9):402–10. Available from: https://pubmed.ncbi.nlm.nih.gov/26313883/ DOI: https://doi.org/10.1590/SO100-720320150005418
Kaddah M, Le-Brech F. Génération No Pilule. Illustrated édition. Paris: Larousse; 2021.
Plu-Bureau G, Raccah-Tebeka B. La balance bénéfices-risques des contraceptions hormonales estroprogestatives. médecine/sciences [Internet]. 2022 [cited 2022 Nov 30]; 38(1):59–69. Available from: https://www.medecinesciences.org/articles/medsci/abs/2022/01/msc200660/msc200660.html DOI: https://doi.org/10.1051/medsci/2021238
Lidegaard Ø, Løkkegaard E, Jensen A, Skovlund CW, Keiding N. Thrombotic Stroke and Myocardial Infarction with Hormonal Contraception. N Engl J Med [Internet]. 2012 Jun 14 [cited 2022 Dec 3]; 366(24):2257–66. Available from: https://www.nejm.org/doi/10.1056/NEJMoa1111840 DOI: https://doi.org/10.1056/NEJMoa1111840
Fairweather D, Rose NR. Women and Autoimmune Diseases. Emerg Infect Dis [Internet]. 2004 Nov [cited 2023 Jan 4]; 10(11):2005–11. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3328995/ DOI: https://doi.org/10.3201/eid1011.040367
Bernier MO, Mikaeloff Y, Hudson M, Suissa S. Combined oral contraceptive use and the risk of systemic lupus erythematosus. Arthritis Care Res [Internet]. 2009 Apr 15 [cited 2023 Jan 4]; 61(4):476–81. Available from: https://onlinelibrary.wiley.com/doi/10.1002/art.24398 DOI: https://doi.org/10.1002/art.24398
Williams WV. Hormonal Contraception and the Development of Autoimmunity: A Review of the Literature. Linacre Q [Internet]. 2017 [cited 2023 Jul 23]; 84(3):275– 95. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5592309/ DOI: https://doi.org/10.1080/00243639.2017.1360065
International Agency for Research on Cancer. IARC. Pharmaceuticals. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans Volume 100A [Internet]. Lyon: International Agency for Research on Cancer (IARC). World Health Organization (who); 2012 [cited 2022 Dec 3]. 435 p. Available from: https://publications.iarc.fr/118
Lidegaard Ø, Nielsen LH, Skovlund CW, Løkkegaard E. Venous thrombosis in users of non-oral hormonal contraception: follow-up study, Denmark 2001-10. BMJ [Internet]. 2012 [cited 2023 Jun 5]; 344:e2990. Available from: https://www.bmj.com/content/344/bmj.e2990 DOI: https://doi.org/10.1136/bmj.e2990
Mirena (levonorgestrel-releasing intrauterine system) [Internet]. 2020 Aug [cited 2022 Dec 4] Available from: https://labeling.bayerhealthcare.com/html/products/pi/Mirena_PI.pdf
DIU au lévonorgestrel : surcroît de grossesses extra-utérines. Prescrire [Internet]. 2023 [cited 2023 Nov 1]; (481):286. Available from: https://www.prescrire.org/Fr/SummaryDetail.aspx?Issueid=481
Meaidi A, Torp-Pedersen C, Lidegaard Ø, Mørch LS. Ectopic Pregnancy Risk in Users of Levonorgestrel-Releasing Intrauterine Systems With 52, 19.5, and 13.5 mg of Hormone. JAMA [Internet]. 2023 [cited 2023 Nov 1]; 329(11):935–7. Avail- able from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10031393/ DOI: https://doi.org/10.1001/jama.2023.0380
Tulandi T. Ectopic pregnancy: Epidemiology, risk factors, and anatomic sites. Up- ToDate [Internet]. 2023 [cited 2023 Nov 1]. Available from: https://medilib.ir/uptodate/show/5481
Huijbregts RPH, Helton ES, Michel KG, Sabbaj S, Richter HE, Goepfert PA. Hor- monal Contraception and HIV-1 Infection: Medroxy progesterone Acetate Suppresses Innate and Adaptive Immune Mechanisms. Endocrinology [Internet]. 2013 [cited 2024 Oct 17]; 154(3):1282. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC3578997/ DOI: https://doi.org/10.1210/en.2012-1850
Wand H, Ramjee G. The effects of injectable hormonal contraceptives on HIV seroconversion and on sexually transmitted infections. AIDS [Internet]. 2012 [cited 2024 Oct 17]; 26(3):375. Available from: https://journals.lww.com/aidsonline/fulltext/2012/01280/the_effects_of_injectable_hormonal_contraceptives.13.aspx DOI: https://doi.org/10.1097/QAD.0b013e32834f990f
Roland N, Neumann A, Hoisnard L, Zureik M, Weill A. Utilisation de progestatifs et risque de méningiome intracrânien: une étude cas-témoins à partir des données du système national des données de santé (SNDS) [Internet]. Saint-Denis: EPI- PHARE – Groupement d’intérêt scientifique (GIS) ANSM-CNAM; 2023 [cited 2023 Jun 30] Available from: https://ansm.sante.fr/uploads/2023/07/21/20230721-rapport-epiphare-progestatifs-meningiomes-22-06-2023.pdf
Roland N, Neumann A, Hoisnard L, Duranteau L, Froelich S, Zureik M. Use of progestogens and the risk of intracranial meningioma: national case-control study. BMJ [Internet]. 2024 Mar 27 [cited 2024 Mar 28]; 384:1–13. Available from: https://www.bmj.com/content/384/bmj-2023-078078 DOI: https://doi.org/10.1136/bmj-2023-078078
Sweeney C, Giuliano A, Baumgartner K, Byers T, Herrick J, Edwards S. Oral, injected and implanted contraceptives and breast cancer risk among U.S. Hispanic and non-Hispanic white women. Int J Cancer [Internet]. 2007 [cited 2022 Dec 5]; 121(11):2517–23. Available from: https://onlinelibrary.wiley.com/doi/abs/10.1002/ijc.22970 DOI: https://doi.org/10.1002/ijc.22970
Fitzpatrick D, Pirie K, Reeves G, Green J, Beral V. Combined and progestagen-only hormonal contraceptives and breast cancer risk: A UK nested case–control study and meta-analysis. PLOS Med [Internet]. 2023 Mar 21 [cited 2023 Mar 26]; 20(3):e1004188. Available from: https://journals.plos.org/plosmedicine/article?id=10.1371/journal.pmed.1004188 DOI: https://doi.org/10.1371/journal.pmed.1004188
Yland J, Bresnick K, Hatch E, Wesselink A, Mikkelsen E, Rothman K. Pregravid contraceptive use and fecundability: prospective cohort study. BMJ [Internet]. 2020 Nov 11 [cited 2023 Jan 5]; 371:m3966. Available from: https://www.bmj.com/content/371/bmj.m3966 DOI: https://doi.org/10.1136/bmj.m3966
Goh T, Hariharan M, Tan C. A longitudinal study of serum iron indices and haemoglobin concentration following copper-IUD insertion. Contraception [Internet]. 1980 Oct 1 [cited 2022 Dec 5]; 22(4):389–95. Available from: https://www.contraceptionjournal.org/article/0010-7824(80)90024-4/abstract DOI: https://doi.org/10.1016/0010-7824(80)90024-4
Borghei A, Qorbani M, Borghei NS, Kazeminejad V, Seifi F. Effects of IUD on iron status in IUD users in Gorgan, Iran. Med J Islam Repub Iran [Internet]. 2011 Nov 10 [cited 2022 Dec 5]; 25(3):131–5. Available from: http://mjiri.iums.ac.ir/article-1-401-en.html
Royer A, Sharman T. Copper Toxicity. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023 [cited 2023 May 3]. Available from: http://www.ncbi.nlm.nih.gov/books/NBK557456/
Kim SK, Romero R, Kusanovic JP, Erez O, Vaisbuch E, Mazaki-Tovi S. The prognosis of pregnancy conceived despite the presence of an intrauterine device (IUD). J Perinat Med [Internet]. 2010 [cited 2022 Dec 19]; 38(1):45–53. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3418877/ DOI: https://doi.org/10.1515/jpm.2009.133
Beksinska M, Issema R, Beesham I, Lalbahadur T, Thomas K, Morrison C, et al. Weight change among women using intramuscular depot medroxyprogesterone acetate, a copper intrauterine device, or a levonorgestrel implant for contraception: Findings from a randomised, multicentre, open-label trial. EClinicalMedicine [Internet]. 2021 Apr 6 [cited 2023 Jan 10]; 34:100800. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8056402/ DOI: https://doi.org/10.1016/j.eclinm.2021.100800
Birnbach M, Lehmann A, Naranjo E, Finkbeiner M. A condom’s footprint - life cycle assessment of a natural rubber condom. Int J Life Cycle Assess [Internet]. 2020 Jun 1 [cited 2023 Jan 2]; 25(6):964–79. Available from: https://link.springer.com/article/10.1007/s11367-019-01701-y DOI: https://doi.org/10.1007/s11367-019-01701-y
Chaddad F, Mello FAO, Tayebi M, Safanelli JL, Campos LR, Amorim MTA, et al. Impact of mining-induced deforestation on soil surface temperature and carbon stocks: A case study using remote sensing in the Amazon rainforest. J South Am Earth Sci [Internet]. 2022 Nov 1 [cited 2023 Sep 8]; 119:103983. Available from: https://www.sciencedirect.com/science/article/pii/S089598112200270X DOI: https://doi.org/10.1016/j.jsames.2022.103983
Jawjit W, Pavasant P, Kroeze C, Tuffrey J. Evaluation of the potential environmental impacts of condom production in Thailand. J Integr Environ Sci [Internet]. 2021 Jan 1 [cited 2023 Jan 2]; 18(1):89–114. Available from: https://www.tandfonline.com/doi/full/10.1080/1943815X.2021.1949354 DOI: https://doi.org/10.1080/1943815X.2021.1949354
Dong D, van Oers L, Tukker A, van der Voet E. Assessing the future environmental impacts of copper production in China: Implications of the energy transition. J Clean Prod [Internet]. 2020 Nov 20 [cited 2023 Sep 8]; 274:122825. Available from: https://www.sciencedirect.com/science/article/pii/S0959652620328705 DOI: https://doi.org/10.1016/j.jclepro.2020.122825
Adetunji C, Olaniyan O, Anani O, Inobeme A, Mathew J. Environmental Impact of Polyurethane Chemistry. In: Polyurethane Chemistry: Renewable Polyols and Iso- cyanates [Internet]. 2021; 393–411. Available from: https://www.researchgate.net/publication/351811523_Environmental_Impact_of_Polyurethane_Chemistry DOI: https://doi.org/10.1021/bk-2021-1380.ch014
Bergman A, Brandt I, Brouwer B, Harisson P, Holmes P, Humfrey C, et al. European workshop on the impact of endocrine disrupters on human health and wildlife. Reports of proceedings [Internet]. Weybridge, UK: European Commission, European Environment Agency, World Health Organisation, uropean Office; 1996 Dec [cited 2023 Jan 3] p. 125. Report No.: CGNA17549ENC. Available from: http://www.iehconsulting.co.uk/IEH_Consulting/IEHCPubs/EndocrineDisrupters/WEYBRIDGE.pdf
Tyler CR, Jobling S. Roach, Sex, and Gender-Bending Chemicals: The Feminization of Wild Fish in English Rivers. BioScience [Internet]. 2008 Dec 1 [cited 2022 Mar 21];58(11):1051–9. Available from: https://academic.oup.com/bioscience/article/58/11/1051/264727 DOI: https://doi.org/10.1641/B581108
Minier C, Caltot G, Leboulanger F, Hill EM. An investigation of the incidence of intersex fish in Seine-Maritime and Sussex region. Analusis [Internet]. 2000 Nov 1 [cited 2023 Jan 2];28(9):801–6. Available from: https://analusis.edpsciences.org/articles/analusis/abs/2000/09/minier/minier.html DOI: https://doi.org/10.1051/analusis:2000280801
Jobling S, Beresford N, Nolan M, Rodgers-Gray T, Brighty GC, Sumpter JP, et al. Altered Sexual Maturation and Gamete Production in Wild Roach (Rutilus rutilus) Living in Rivers That Receive Treated Sewage Effluents1. Biol Reprod [Internet]. 2002 Feb 1 [cited 2023 Jan 4];66(2):272–81. Available from: https://academic.oup.com/biolreprod/article/66/2/272/2723352 DOI: https://doi.org/10.1095/biolreprod66.2.272
Qin X, Lai KP, Wu RSS, Kong RYC. Continuous 17α-ethinylestradiol exposure impairs the sperm quality of marine medaka (Oryzias melastigma). Mar Pollut Bull [Internet]. 2022 Oct 1 [cited 2023 Jan 6];183:114093. Available from: https://www.sciencedirect.com/science/article/pii/S0025326X22007755 DOI: https://doi.org/10.1016/j.marpolbul.2022.114093
Saaristo M, Johnstone CP, Xu K, Allinson M, Wong BBM. The endocrine disruptor, 17α-ethinyl estradiol, alters male mate choice in a freshwater fish. Aquat Toxicol [Internet]. 2019 Mar 1 [cited 2023 Jan 6];208:118–25. Available from: https://www.sciencedirect.com/science/article/pii/S0166445X18309408 DOI: https://doi.org/10.1016/j.aquatox.2019.01.006
Kidd KA, Blanchfield PJ, Mills KH, Palace VP, Evans RE, Lazorchak JM, et al. Collapse of a fish population after exposure to a synthetic estrogen. Proc Natl Acad Sci [Internet]. 2007 May 22 [cited 2023 Jan 2];104(21):8897–901. Available from: https://www.pnas.org/doi/10.1073/pnas.0609568104 DOI: https://doi.org/10.1073/pnas.0609568104
Margel D, Fleshner NE. Oral contraceptive use is associated with prostate cancer: an ecological study. BMJ Open [Internet]. 2011 Jan 1 [cited 2023 Jan 6];1(2):e000311. Available from: https://bmjopen.bmj.com/content/1/2/e000311 DOI: https://doi.org/10.1136/bmjopen-2011-000311
Bonkhoff H. Estrogen receptor signaling in prostate cancer: Implications for carcinogenesis and tumor progression. The Prostate [Internet]. 2018 [cited 2023 Jan 10];78(1):2–10. Available from: https://onlinelibrary.wiley.com/doi/abs/10.1002/pros.23446 DOI: https://doi.org/10.1002/pros.23446
Rolland M, Le Moal J, Wagner V, Royère D, De Mouzon J. Decline in semen concentration and morphology in a sample of 26 609 men close to general population between 1989 and 2005 in France. Hum Reprod [Internet]. 2013 Feb 1 [cited 2023 Jan 4];28(2):462–70. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4042534/ DOI: https://doi.org/10.1093/humrep/des415
Marques-Pinto A, Carvalho D. Human infertility: are endocrine disruptors to blame? Endocr Connect [Internet]. 2013 Sep 17 [cited 2023 Jan 13];2(3):R15–29. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3845732/ DOI: https://doi.org/10.1530/EC-13-0036
Waller DK, Gallaway MS, Taylor LG, Ramadhani TA, Canfield MA, Scheuerle A, et al. Use of Oral Contraceptives in Pregnancy and Major Structural Birth Defects in Offspring. Epidemiology [Internet]. 2010 Mar [cited 2023 Jan 10];21(2):232–93. Available from: https://journals.lww.com/epidem/Fulltext/2010/03000/Use_of_Oral_ Contraceptives_in_Pregnancy_and_Major.11.aspx DOI: https://doi.org/10.1097/EDE.0b013e3181c9fbb3
Delbès G, Levacher C, Habert R. Estrogen effects on fetal and neonatal testicular development. Reproduction [Internet]. 2006 Oct 1 [cited 2023 Feb 15];132(4):527–38. Available from: https://rep.bioscientifica.com/view/journals/ rep/132/4/1320527.xml DOI: https://doi.org/10.1530/rep.1.01231
Lyall K, Pauls DL, Santangelo S, Spiegelman D, Ascherio A. Maternal Early Life Factors Associated with Hormone Levels and the Risk of Having a Child with an Autism Spectrum Disorder in the Nurses Health Study II. J Autism Dev Disord [Internet]. 2011 May 1 [cited 2023 Oct 10];41(5):618–27. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3494408/ DOI: https://doi.org/10.1007/s10803-010-1079-7
Strifert K. An epigenetic basis for autism spectrum disorder risk and oral contraceptive use. Med Hypotheses [Internet]. 2015 Dec 1 [cited 2023 Oct 10];85(6):1006–11. Available from: https://www.sciencedirect.com/science/article/pii/S0306987715003230 DOI: https://doi.org/10.1016/j.mehy.2015.09.001
Baker D, Keogh S, Luchsinger G, Roseman M, Sedgh G, Solo J. Seeing the Un- seen: The case for action in the neglected crisis of unintended pregnancy [Inter- net]. New York: United Nations Population Fund; 2022 [cited 2022 Oct 26] p. 160. Available from: https://www.unfpa.org/publications/seeing-the-unseen
Hernandez JH, Babazadeh S, Anglewicz PA, Akilimali PZ. As long as (I think) my husband agrees...: role of perceived partner approval in contraceptive use among couples living in military camps in Kinshasa, DRC. Reprod Health [Internet]. 2022 Jan 12 [cited 2023 Aug 3];19(1):6. Available from: https://reproductive-health-journal.biomedcentral.com/articles/10.1186/s12978-021-01256-y DOI: https://doi.org/10.1186/s12978-021-01256-y
Kavanaugh ML, Lindberg LD, Frost J. Factors influencing partners involvement in women’s contraceptive services. Contraception [Internet]. 2012 Jan 1 [cited 2023 Aug 3];85(1):83–90. Available from: https://www.contraceptionjournal.org/article/S0010-7824%2811%2900203-4/fulltext DOI: https://doi.org/10.1016/j.contraception.2011.04.018
Cadiergues D. La connaissance des hommes sur la contraception: étude quantitative auprès d’hommes de 15-55 ans [Thèse d’exercice]. [France]: Université Paris Diderot - Paris 7 (1970-2019). UFR de médecine; 2015.
Lewis DA, Martins SL, Gilliam ML. Partner Roles in Contraceptive Use: What Do Adolescent Mothers Say? J Pediatr Adolesc Gynecol [Internet]. 2012 Dec [cited 2023 Aug 3]; 25(6):396–400. Available from: https://www.em-consulte.com/article/766999/tableaux/partner-roles-in-contraceptive-use-what-do-adolesc DOI: https://doi.org/10.1016/j.jpag.2012.08.003
Masih N. Gender Disparities in Reproductive Health and Family Planning Choic- es. In: Sustainable Development Through Gender Equality. New Delhi: Pentagon Press; 2018. pp. 48-57.
Anawalt B, Roth M, Ceponis J, Surampudi V, Amory J, Swerdloff R. Combined nestorone–testosterone gel suppresses serum gonadotropins to concentrations associated with effective hormonal contraception in men. Andrology [Internet]. 2019 [cited 2023 Aug 6]; 7(6):878–87. Available from: https://onlinelibrary.wiley.com/doi/abs/10.1111/andr.12603 DOI: https://doi.org/10.1111/andr.12603
Nieschlag E. Use of testosterone alone as hormonal male contraceptive. Basic Clin Androl [Internet]. 2012 Sep [cited 2023 Aug 6]; 22(3):136–40. Available from: https://bacandrology.biomedcentral.com/articles/10.1007/s12610-012-0187-y DOI: https://doi.org/10.1007/s12610-012-0187-y
.Yuen F, Thirumalai A, Pham C, Swerdloff R, Anawalt B, Liu P. Daily Oral Administration of the Novel Androgen 11β-MNTDC Markedly Suppresses Serum Gonado- tropins in Healthy Men. J Clin Endocrinol Metab [Internet]. 2020 Jan 24 [cited 2023 Aug 6]; 105(3):e835–47. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7049261/ DOI: https://doi.org/10.1210/clinem/dgaa032
Thirumalai A, Ceponis J, Amory J, Swerdloff R, Surampudi V, Liu P. Effects of 28 Days of Oral Dimethandrolone Undecanoate in Healthy Men: A Prototype Male Pill. J Clin Endocrinol Metab [Internet]. 2019 Feb 1 [cited 2023 Aug 6]; 104(2):423–32. Available from: https://academic.oup.com/jcem/article/104/2/423/5105935?login=false DOI: https://doi.org/10.1210/jc.2018-01452
Cicchini-blot C. La contraception testiculaire thermique (CTT) [Internet]. Biogroup. 2022 [cited 2023 Aug 6]. Available from: https://biogroup.fr/actualites/contraception-testiculaire-thermique-ctt/
A non-hormonal pill could soon expand men’s birth control options [Internet]. 2022 [cited 2023 Aug 6]. Available from: https://www.youtube.com/watch?v=Gs-BQ9Obgv1Y
American Chemical Society. ACS. American Chemical Society. 2022 [cited 2023 Aug 6]. A non-hormonal pill could soon expand men’s birth control options. Available from: https://www.acs.org/pressroom/newsreleases/2022/march/non-hormonal-pill-could-soon-expand-mens-birth-control-options.html
Chang Z, Qin W, Zheng H, Schegg K, Han L, Liu X, et al. Triptonide is a reversible non-hormonal male contraceptive agent in mice and non-human primates. Nat Commun [Internet]. 2021 Feb 23 [cited 2023 Aug 6]; 12:1253. Available from: https://pubmed.ncbi.nlm.nih.gov/33623031/ DOI: https://doi.org/10.1038/s41467-021-21517-5
Colagross-Schouten A, Lemoy MJ, Keesler RI, Lissner E, VandeVoort CA. The contraceptive efficacy of intravas injection of VasalgelTM for adult male rhesus monkeys. Basic Clin Androl [Internet]. 2017 Feb 7 [cited 2023 Aug 6]; 27(1):4. Available from: https://pubmed.ncbi.nlm.nih.gov/28191316/ DOI: https://doi.org/10.1186/s12610-017-0048-9
Khliwani B, Badar A, Ansari A, Lohiya N. RISUG® as a male contraceptive: journey from bench to bedside. Basic Clin Androl. Basic Clin Androl [Internet]. 2020 Feb 13 [cited 2022 Oct 26]; 30(2). Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7017607/ DOI: https://doi.org/10.1186/s12610-020-0099-1
Anderson P, Bolton D, Lawrentschuk N. Pd42-08 preliminary results of a first in human dose-ranging clinical trial of adam®, a nonhormonal hydrogel-based male contraceptive. J Urol [Internet]. 2023 Apr [cited 2023 Jun 15]; 209(Supplement 4):e1114. Available from: https://www.auajournals.org/doi/abs/10.1097/JU.0000000000003352.08 DOI: https://doi.org/10.1097/JU.0000000000003352.08
O’rand M, Widgren E, Sivashanmugam P, Richardson R, Hall S, French F. Re- versible immunocontraception in male monkeys immunized with eppin. Science [Internet]. 2004 Nov 12 [cited 2023 Aug 6]; 306(5699):1189–90. Available from: https://www.science.org/doi/10.1126/science.1099743?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%20%200pubmed DOI: https://doi.org/10.1126/science.1099743
Mariani NAP, Camara AC, Silva AAS, Raimundo TRF, Andrade JJ, Andrade AD. Epididymal protease inhibitor (EPPIN) is a protein hub for seminal vesicle-secreted protein SVS2 binding in mouse spermatozoa. Mol Cell Endocrinol [Internet]. 2020 Apr 15 [cited 2023 Aug 6]; 506:110754. Available from: https://www.sciencedirect.com/science/article/pii/S030372072030054X DOI: https://doi.org/10.1016/j.mce.2020.110754
Scendoni R, Cingolani M, Cembriani F, Fedeli P, Tambone V, Terranova C. Over-the-counter emergency contraception in Italy: ethical reflections and medico-legal issues. Front Glob Womens Health [Internet]. 2023 Sep 18 [cited 2024 Oct 19]; 4. Available from: https://www.frontiersin.org/journals/global-womens-health/articles/10.3389/fgwh.2023.1205208/full DOI: https://doi.org/10.3389/fgwh.2023.1205208
Mozzanega B, Gizzo S, Di Gangi S, Cosmi E, Nardelli GB. Ulipristal Acetate: Critical Review About Endometrial and Ovulatory Effects in Emergency Contraception. Reprod Sci [Internet]. 2014 Jun 1 [cited 2024 Oct 19]; 21(6):678–85. Avail- able from: https://doi.org/10.1177/1933719113519178 DOI: https://doi.org/10.1177/1933719113519178
Gómez-Elías MD, May M, Munuce MJ, Bahamondes L, Cuasnicú PS, Cohen DJ. A single post-ovulatory dose of ulipristal acetate impairs post-fertilization events in mice. Mol Hum Reprod [Internet]. 2019 May 1 [cited 2024 Oct 19]; 25(5):257–64. Available from: https://doi.org/10.1093/molehr/gaz013 DOI: https://doi.org/10.1093/molehr/gaz013
Ecochard R, Garmier-Billard M, Iwaz J. The Menstrual Cycle Phases Are Like “Body Seasons.” Insights Anthropol [Internet]. 2019 Sep 7 [cited 2023 Mar 3];3(2). Available from: https://scholars.direct/Articles/anthropology/iap-3-022.php?jid=anthropology DOI: https://doi.org/10.36959/763/502
Ecochard R, Pinguet F, Ecochard I, De Gouvello R, Guy M, Huy F. Analyse des échecs de la planification familiale naturelle. A propos de 7007 cycles d’utilisation. Contracept Fertil Sex. 1998;26(4):291–6.
Manhart MD, Fehring RJ. The Association of Family Planning Methods With the Odds of Divorce Among Women in the 2015–2019 National Survey of Family Growth. J Divorce Remarriage [Internet]. 2023 Jan 2 [cited 2023 Jul 14];64(1):55– 66. Available from: https://www.tandfonline.com/doi/full/10.1080/10502556.2023.2179837 DOI: https://doi.org/10.1080/10502556.2023.2179837